182 related articles for article (PubMed ID: 7531851)
1. Age-related behavioural, neurochemical and radioligand binding changes in the central 5-HT system of Sprague-Dawley rats.
Robson L; Gower AJ; Kendall DA; Marsden CA
Psychopharmacology (Berl); 1993; 113(2):274-81. PubMed ID: 7531851
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the 5-HT receptor subtypes involved in the motor behaviours produced by intrathecal administration of 5-HT agonists in rats.
Fone KC; Robinson AJ; Marsden CA
Br J Pharmacol; 1991 Jun; 103(2):1547-55. PubMed ID: 1832068
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
Kleven MS; Assié MB; Koek W
J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
[TBL] [Abstract][Full Text] [Related]
4. Effect of isolation rearing on 5-HT agonist-induced responses in the rat.
Wright IK; Ismail H; Upton N; Marsden CA
Psychopharmacology (Berl); 1991; 105(2):259-63. PubMed ID: 1839066
[TBL] [Abstract][Full Text] [Related]
5. Effects of cold stress on some 5-HT1A, 5-HT1C and 5-HT2 receptor-mediated responses.
Zamfir O; Broqua P; Baudrie V; Chaouloff F
Eur J Pharmacol; 1992 Aug; 219(2):261-9. PubMed ID: 1385172
[TBL] [Abstract][Full Text] [Related]
6. Behavioural evidence for functional interactions between 5-HT-receptor subtypes in rats and mice.
Berendsen HH; Broekkamp CL
Br J Pharmacol; 1990 Nov; 101(3):667-73. PubMed ID: 2150180
[TBL] [Abstract][Full Text] [Related]
7. Effects of corticosterone on 5-HT1A and 5-HT2 receptor binding and on the receptor-mediated behavioral responses of rats.
Takao K; Nagatani T; Kitamura Y; Yamawaki S
Eur J Pharmacol; 1997 Aug; 333(2-3):123-8. PubMed ID: 9314024
[TBL] [Abstract][Full Text] [Related]
8. The 5-HT1A receptor full agonist, 8-OH-DPAT inhibits ACTH-induced 5-HT2A receptor hyperfunction in rats: involvement of 5-HT1A receptors in the DOI-induced wet-dog shakes in ACTH-treated rats.
Kitamura Y; Kitagawa K; Fujitani Y; Shibata K; Araki H; Sendou T; Gomita Y
Biol Pharm Bull; 2007 Jan; 30(1):117-20. PubMed ID: 17202670
[TBL] [Abstract][Full Text] [Related]
9. Destruction of the nucleus raphe obscurus and potentiation of serotonin-mediated behaviors following administration of the neurotoxin 3-acetylpyridine.
Wieland S; Kreider MS; McGonigle P; Lucki I
Brain Res; 1990 Jun; 520(1-2):291-302. PubMed ID: 1698505
[TBL] [Abstract][Full Text] [Related]
10. Behavioural and neurochemical evidence for the decrease of brain extracellular 5-HT by the antidepressant drug tianeptine.
Datla KP; Curzon G
Neuropharmacology; 1993 Sep; 32(9):839-45. PubMed ID: 7694170
[TBL] [Abstract][Full Text] [Related]
11. The effects of long-term treatment with the 5-HT1A receptor agonist 8-OH-DPAT and the 5-HT2/1C receptor agonist DOI in the neonatal rat.
Johansson-Wallsten CE; Berg M; Meyerson BJ
Eur J Pharmacol; 1993 Oct; 243(2):149-54. PubMed ID: 8276064
[TBL] [Abstract][Full Text] [Related]
12. Different effects on the responses of functional pre- and postsynaptic 5-HT1A receptors by repeated treatment of rats with the 5-HT1A receptor agonist 8-OH-DPAT.
Larsson LG; Rényi L; Ross SB; Svensson B; Angeby-Möller K
Neuropharmacology; 1990 Feb; 29(2):85-91. PubMed ID: 1691832
[TBL] [Abstract][Full Text] [Related]
13. Effect of selective serotonin agonists on basal, corticotrophin-releasing hormone- and vasopressin-induced ACTH release in vitro from rat pituitary cells.
Calogero AE; Bagdy G; Moncada ML; D'Agata R
J Endocrinol; 1993 Mar; 136(3):381-7. PubMed ID: 8386213
[TBL] [Abstract][Full Text] [Related]
14. Effects of the serotonin1A agonist, 8-hydroxy-2-(di-n-propylamino)tetralin on neurochemical responses to stress.
Saphier D; Welch JE
J Neurochem; 1995 Feb; 64(2):767-76. PubMed ID: 7530293
[TBL] [Abstract][Full Text] [Related]
15. Chronic, combined treatment with desipramine and mianserin: enhanced 5-HT1A receptor function and altered 5-HT1A/5-HT2 receptor interaction in rats.
Lund A; Mjellem N
Pharmacol Biochem Behav; 1993 Aug; 45(4):777-83. PubMed ID: 8415816
[TBL] [Abstract][Full Text] [Related]
16. The effects of Ca2+ antagonists and hydralazine on central 5-hydroxytryptamine biochemistry and function in rats and mice.
Green AR; DeSouza RJ; Davies EM; Cross AJ
Br J Pharmacol; 1990 Jan; 99(1):41-6. PubMed ID: 1691944
[TBL] [Abstract][Full Text] [Related]
17. Differential serotoninergic and dopaminergic activities of the (R)- and the (S)-enantiomers of 2-(di-n-propylamino)tetralin.
Yu H; Liu Y; Malmberg A; Mohell N; Hacksell U; Lewander T
Eur J Pharmacol; 1996 May; 303(3):151-62. PubMed ID: 8813561
[TBL] [Abstract][Full Text] [Related]
18. 5-HT1A and muscarinic acetylcholine receptors jointly regulate passive avoidance behavior.
Riekkinen P
Eur J Pharmacol; 1994 Sep; 262(1-2):77-90. PubMed ID: 7813581
[TBL] [Abstract][Full Text] [Related]
19. Effect of reserpine on behavioural responses to agonists at 5-HT1A, 5-HT1B, 5-HT2A, and 5-HT2C receptor subtypes.
Heslop KE; Curzon G
Neuropharmacology; 1999 Jun; 38(6):883-91. PubMed ID: 10465692
[TBL] [Abstract][Full Text] [Related]
20. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
Goodwin GM; Green AR
Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
